Toggle search
Toggle menu
406
21
32
6.1K
Pharmacopedia
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Drilldown: Medicines

More actions

Choose a table:


Medicines > classes : Barbiturate or Classic Psychedelic or Dissociative

Use the filters below to narrow your results.

generic:
brand:
None (87) · Amytal (1) · Brevital (1) · Delysid (historical, Sandoz, withdrawn 1965) (1) · DXM (1) · DXO (1) · Luminal (1) · Nembutal (1) · Pentothal (1) · Seconal (1) · Spravato (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (26) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · None (3) · GABAA potentiator and direct activator (3) · NMDA antagonist (3) · Contains LSA (2) · Contains mescaline (2) · GABAA potentiator; ultra-short-acting (2) · NMDA antagonist; sigma receptor agonist (2)
uses:
None (96) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1)
starting dose:
None (96) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1)
preparations:
None (96) · 28 mg/device (each dose uses 2 devices) (1)
fda max:
None (96) · 84 mg per session (1)
routes:
None (95) · Intranasal (under direct medical supervision) (1) · Oral (1)
onset:
None (95) · 30–60 minutes (1) · Within hours of first administration (1)
duration:
None (95) · 8–12 hours (1) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1)
halflife:
None (95) · 3–5 hours (1) · ~7-12 hours (1)
bioavailability:
None (95) · 70–90% (oral) (1) · ~48% intranasal (1)
pregnancy:
None (95) · Avoid; may cause fetal harm (1) · Not established (1)
legal:
None (95) · Rx, Schedule III (US). REMS program required. (1) · Schedule I (United States) (1)

Showing below up to 97 results in range #1 to #97.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"